SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Bellerophon Therapeutics Q1 EPS $(1.080) Down From $(0.010) YoY

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(1.080) per share. This is a 10700 percent decrease over losses of $(0.010) per share from the same period last year.

Benzinga · 05/11/2020 20:05

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(1.080) per share. This is a 10700 percent decrease over losses of $(0.010) per share from the same period last year.